Joel Nordin defended his PhD 2017 regarding purification and engineering of Extracellular Vesicles (EVs) in the EL Andaloussi group. He did his PostDoc in Youshitsugu Aokis group at NCNP, Tokyo, Japan working on novel cellular therapies for muscular diseases and translational muscle research. Since 2022 he has been a PI at the Department of Laboratory Medicine at KI, working on translational cell and gene therapy. Mainly working towards targeted in vivo delivery of macromolecules such as CRISPR to T cells, hematopoietic stem cells and CNS by engineered EVs. He has spearheaded the loading of macromolecules and targeting of EVs. He is furthermore an MD at the department of Clinical Immunology and Transfusion Medicine at Karolinska University Hospital, where he is the co-founder of a precision medicine center in Transplantation Immunology that aims to bring novel precision medicine diagnostic tests for transplanted patients into clinical routine.
Joel Nordin
Assistant Professor, Karolinska Institutet, and Resident in Clinical Immunology and Transfusion Medicine, Karolinska University Hospital
